Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
Prostate cancer (PCa) is the most common noncutaneous cancer diagnosis and the second leading cause of cancer-related deaths among men in the United States. Effective treatment modalities for advanced metastatic PCa are limited. Immunotherapeutic strategies based on T cells and antibodies represent...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712678/ |